Validation of serological testing for anti-Treponema pallidum from postmortem blood on the siemens-BEP-III automatic system

Transfusion Medicine and Hemotherapy

Volumn 40, Issue 6, 2013, Pages 403-408

  Kalus, Ulrich ^a   Wilkemeyer, Ina ^a   Pruss, Axel ^a   Caspari, Gregor ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b LADR GmbH   (Germany)

Author keywords

Blood testing; Infectious disease serology; Postmortem blood; Tissue donation; Treponema pallidum

Indexed keywords

BACTERIUM ANTIBODY; HEMOGLOBIN; TREPONEMA PALLIDUM ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; BLOOD; BLOOD ANALYSIS EQUIPMENT; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA; DILUTION; DONOR; FALSE POSITIVE RESULT; FEMALE; HEMOLYSIS; HUMAN; HUMAN TISSUE; MALE; REVIEW; SEROLOGY; SERUM; STANDARD; TRANSPLANTATION; TREPONEMA PALLIDUM; VALIDATION PROCESS; YOUNG ADULT;

EID: 84896528553     PISSN: 16603796     EISSN: 16603818     Source Type: Journal    
DOI: 10.1159/000354070     Document Type: Review

References (12)

1. Federal Ministry of Justice: TPG-Gewebeverordnung (TPG-GewV) Regulation on quality and safety requirements regarding tissue removal and transplantation according to the German transplant law (in German). 26 March 2008, BGBl I: 512.
2. European Union: Directive 2004/23/EC of the European Parliament and of the Council of 31 March 2004 on Setting Standards of Quality and Safety for the Donation, Procurement, Testing, Processing, Preservation, Storage and Distribution of Human Tissues and Cells. Official Journal of the European Union, 04.07,2004, 102:48-58.
3. European Union: Commission Directive 2006/17/ EC of 8 February 2006 Implementing Directive 2004/23/EC of the European Parliament and of the Council as Regards Certain Technical Requirements for the Donation, Procurement and Testing of Human Tissues and Cells. Official Journal of the European Union, 02.09,2006, 38:40-52.
4. Kalus U, Wilkemeyer I, Caspari G, Schroeter J, Pruss A: Validation of the serological testing for anti-HIV-1/2,Validation of the serological testing for anti-HIV-1/2, Anti-HCV, HBsAg, and Anti-HBc from post-mortem blood on the Siemens-BEP-III Automatic System. Transfus Med Hemother 2011;38:365-372.
5. Siemens Enzygnost Syphilis: Enzyme Immunoassay for the Qualitative Detection of Hepatitis B (surface) Antigen in Human Serum or Plasma; Edition: December 2008.
6. RKI: Infektionsepidemiologisches Jahrbuch für 2011. Berlin, 2012. www.rki.de/DE/Content/Infekt/ Jahrbuch/Jahrbuch-2011.pdf.
7. Pruss A, Hansen A, Kao M, Gürtler L, Pauli G, Benedix F, Von Versen R: Comparison of the efficacy of virus inactivation methods in allogeneic avital bone tissue transplants. Cell Tissue Bank. 2001; 2:201-215.
8. Hagedorn HJ. Aktuelle Aspekte der Syphilisdiagnostik. Immun Infekt 1993;21:94-99.
9. De Schryver A, Meheus A: Syphilis and blood transfusion: a global perspective. Transfusion 1990; 30:844-847.
10. Hoover KW, Radolf JD: Serodiagnosis of syphilis in the recombinant era: reversal of fortune. J Infect Dis 2011;204:1295-1256.
11. Gessoni G, Barin P, Frigato A, Fezzi M, de Fusco G, Arreghini N, Galli P, Marchiori G: The stability of hepatitis C virus RNA after storage at +4 degrees C. J Viral Hepat 2000;7:283-286.
12. Edler C, Wulff B, Schröder AS, Wilkemeyer I, Polywka S, Meyer T, Kalus U, Pruss A: A prospective time-course study on serological testing for human immunodeficiency virus, hepatitis B virus and hepatitis C virus with blood samples taken up to 48 h after death. J Med Microbiol 2011;60:920-926.